CEJEMLY
Concentrate for solution for infusion, 600mg
RxActive license
Active substance (INN)
sugemalimab
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength600mg
PackagingUkupno 2 bočice staklene sa po 20ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerManufacturing Packaging Farmaca (MPF) B.V., Netherlands
Therapeutic groupAntineoplastic and immunomodulating agents (L01FF11)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateAugust 13, 2025
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026